Conjunctivitis Market Size & Share, By Type (Bacterial Conjunctivitis, Viral Conjunctivitis, and Allergic Conjunctivitis), Patients Type (Pediatric and Adults), Drug Class (Antibiotics, Anti-Histaminic, Decongestant, Steroid Drugs, Others) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Conjunctivitis Market, By Type The global conjunctivitis market is segmented by type into bacterial conjunctivitis, viral conjunctivitis, and allergic conjunctivitis. Bacterial conjunctivitis is caused by bacterial infection and is commonly treated with antibiotics. Viral conjunctivitis is caused by viral infections and is usually self-limiting. Allergic conjunctivitis is triggered by allergens and is treated with anti-histaminic drugs to alleviate symptoms. Conjunctivitis Market, By Patients Type The conjunctivitis market is segmented by patients type into pediatric and adults. Pediatric patients are more prone to viral and bacterial conjunctivitis due to their underdeveloped immune systems. On the other hand, adults are more likely to suffer from allergic conjunctivitis due to exposure to environmental allergens. Conjunctivitis Market, By Drug Class The market is further segmented by drug class into antibiotics, anti-histaminic, decongestant, steroid drugs, and others. Antibiotics are commonly prescribed for bacterial conjunctivitis, while anti-histaminic drugs are used for allergic conjunctivitis. Decongestants help reduce redness and swelling, and steroid drugs are prescribed for severe cases. Other drug classes include lubricants and combination medications for symptom relief.